1st Quarter - Report

CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. for ALPHA-1 FOUNDATION

Period 1st Quarter 2018 Filed Apr 17, 2018 Signed by Katina Pierce

Official filing
Firm
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C.
Client
ALPHA-1 FOUNDATION
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA drug development and clinical trials; Precision Medicine Initiative; Patient Access to Care

LobbyistCovered position, as disclosed
LYLE B DENNIS —
JOHANNA GRAY —
ERIKA MILLER —

Contacted: Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Medicare/Medicaid MMM

CMS coverage policies - re: oxygen, Medicare reimbursement

LobbyistCovered position, as disclosed
LYLE B DENNIS —
JOHANNA GRAY —
ERIKA MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH); Food & Drug Administration (FDA)

Budget/Appropriations BUD

H.R.3358/S.1771 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2018 HR 1625, Consolidated Appropriations Act

LobbyistCovered position, as disclosed
LYLE B DENNIS —
JOHANNA GRAY Intern, Sen. Barack Obama
ERIKA MILLER Intern, Rep. Steve Rothman

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); SENATE

Bills named: S. 1771 (115th), H.R. 1625 (115th), H.R. 3358 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.